April 2, 2008
HONOLULU, Hawaii—A recent study at the University of Hawaii, Honolulu, conducted a double blind, placebo-controlled study with 108 women lacking sexual desire, age 22 to 73, to determine the role of ArginMax®, a dietary supplement for enhancement of female sexual dysfunction, on sexual function in women (J Sex Marital Ther. 2006;32(5):369-78) (DOI: 10.1080/00926230600834901). Fifty-five women received ArginMax for women, containing L-arginine, ginseng, ginkgo, damiana, mulitvitamins and minerals; and 53 received a placebo, all at different menopausal status. After four weeks, premenopausal women on ArginMax reported significant improvement in their level of sexual desire (p=.03) and satisfaction with overall sex life (p=.03), compared with the placebo group; frequency of sexual desire (p=.05) and frequency of intercourse (p=0.01) also increased. The primary improvements in perimenopausal women was in frequency of intercourse (p=.002), satisfaction with sexual relationship (p=.03) and vaginal dryness (p=.03), compared with the placebo group. Postmenopausal women showed a 51 percent increase in level of sexual desire compared with an 8 percent increase in the placebo group (p=.008). This study will be presented at the American Association of Sexuality Educators, Counselors and Therapists (AASECT) 40th Annual Conference, New Orleans, June 25 to 29, 2008.
You May Also Like
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023
More bioavailable hyaluronic acid complex for today’s beauty-from-within consumer – snapshotSep 18, 2023